DK0654036T3 - Liponucleotides of seconucleosides, their preparation and their use as antiviral drugs. - Google Patents

Liponucleotides of seconucleosides, their preparation and their use as antiviral drugs.

Info

Publication number
DK0654036T3
DK0654036T3 DK93917764.8T DK93917764T DK0654036T3 DK 0654036 T3 DK0654036 T3 DK 0654036T3 DK 93917764 T DK93917764 T DK 93917764T DK 0654036 T3 DK0654036 T3 DK 0654036T3
Authority
DK
Denmark
Prior art keywords
seconucleosides
liponucleotides
preparation
antiviral drugs
seco
Prior art date
Application number
DK93917764.8T
Other languages
Danish (da)
Inventor
Harald Zilch
Dieter Herrmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of DK0654036T3 publication Critical patent/DK0654036T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention concerns phospholipid derivatives of seco-nucleosides, in which a lipid with a substituted three-carbon-atom basic structure is linked to a seco-nucleoside via a phosphate or thiophosphate group. The invention also concerns the use of such derivatives as anti-viral drugs.
DK93917764.8T 1992-08-08 1993-08-06 Liponucleotides of seconucleosides, their preparation and their use as antiviral drugs. DK0654036T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226279A DE4226279A1 (en) 1992-08-08 1992-08-08 Lipo nucleotides of seco-nucleosides, their production and their use as antiviral drugs

Publications (1)

Publication Number Publication Date
DK0654036T3 true DK0654036T3 (en) 1997-11-03

Family

ID=6465143

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917764.8T DK0654036T3 (en) 1992-08-08 1993-08-06 Liponucleotides of seconucleosides, their preparation and their use as antiviral drugs.

Country Status (20)

Country Link
EP (1) EP0654036B1 (en)
JP (1) JP3479299B2 (en)
KR (1) KR100243440B1 (en)
CN (1) CN1040984C (en)
AT (1) ATE152114T1 (en)
AU (1) AU672994B2 (en)
CA (1) CA2141030A1 (en)
DE (2) DE4226279A1 (en)
DK (1) DK0654036T3 (en)
ES (1) ES2104163T3 (en)
FI (1) FI109699B (en)
GR (1) GR3023960T3 (en)
HU (1) HUT72605A (en)
IL (1) IL106588A (en)
MX (1) MX9304676A (en)
NO (1) NO304986B1 (en)
NZ (1) NZ254813A (en)
TW (1) TW306924B (en)
WO (1) WO1994003465A1 (en)
ZA (1) ZA935718B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
DE4402492A1 (en) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Process for the production of asymmetrical phosphoric acid diesters
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
KR100389558B1 (en) * 2000-10-11 2003-06-27 주식회사 한스환경엔지니어링 Surface Treating Fabric For FRP

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE4026265A1 (en) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PRODUCTION AND THEIR USE AS ANTIVIRAL MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
FI950533A0 (en) 1995-02-07
CN1040984C (en) 1998-12-02
NO950445D0 (en) 1995-02-07
EP0654036A1 (en) 1995-05-24
TW306924B (en) 1997-06-01
NZ254813A (en) 1996-05-28
KR950702998A (en) 1995-08-23
AU4708293A (en) 1994-03-03
ATE152114T1 (en) 1997-05-15
FI109699B (en) 2002-09-30
DE4226279A1 (en) 1994-02-10
HUT72605A (en) 1996-05-28
ZA935718B (en) 1995-02-06
IL106588A0 (en) 1993-12-08
FI950533A (en) 1995-02-07
GR3023960T3 (en) 1997-09-30
HU9500374D0 (en) 1995-03-28
JP3479299B2 (en) 2003-12-15
NO950445L (en) 1995-02-07
NO304986B1 (en) 1999-03-15
CA2141030A1 (en) 1994-02-09
IL106588A (en) 1998-01-04
CN1085908A (en) 1994-04-27
MX9304676A (en) 1994-03-31
ES2104163T3 (en) 1997-10-01
DE59306286D1 (en) 1997-05-28
KR100243440B1 (en) 2000-03-02
AU672994B2 (en) 1996-10-24
EP0654036B1 (en) 1997-04-23
WO1994003465A1 (en) 1994-02-17
JPH08500345A (en) 1996-01-16

Similar Documents

Publication Publication Date Title
MX9202851A (en) PHOSPHATE DERIVATIVES OF 4-DESMETILEPIPODOFILOTOXINA GLUCOSIDES AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM.
FI945363A (en) Novel mercaptoacetylamidopyridazo (1,2) pyridazine, pyrazolo (1,2) pyridazine, pyridazo (1,2-a) (1,2) diazepine and pyrazolo (1,2-a) (1,2) diazepine derivatives, which are useful as inhibitors of encephalase and ACE
MX9203126A (en) DERIVATIVES OF SULFONILUREA AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DK260386D0 (en) PYRIMIDINE DERIVATIVES AND THEIR USE AS MEDICINES
ATE137242T1 (en) COVALENT-THER LIPIDENUCLEOSIDE CONJUGATES
FI891283A0 (en) IFOSFAMID-MESNA-LYOFILISAT AND FOERFARANDE FOER DESS FRAMSTAELLNING.
ES2043665T3 (en) 6,11-DIHIDRO-11- (4-PIPERIDILIDEN) -5H-BENZO- (5,6) -CICLOHEPTA- (1,2-B) -PIRIDINS AND COMPOSITIONS AND METHODS OF USE.
ES2045484T3 (en) NEW DERIVATIVES OF VITAMIN D: THERAPEUTIC APPLICATIONS AND TO THE DOSAGES OF METABOLITES OF VITAMIN D.
DK0654036T3 (en) Liponucleotides of seconucleosides, their preparation and their use as antiviral drugs.
MX9303709A (en) SUBSTITUTED PURINE NUCLEOSIDES AND INTERMEDIARIES OF THE SAME, WHICH HAVE ANTI-VIRAL AND ANTI-CANCERIGEN ACTIVITY AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES2056153T3 (en) EXPECTORANT THAT INCLUDES A HYDROXIALKYLCHYSTEINE DERIVATIVE.
NO982754L (en) Phospholipid derivatives of phosphonocarboxylic acids, preparation of such derivatives and use of the derivatives as antiviral drugs
AR241022A2 (en) Glycerin-ether phosphatides, their preparation and use
ES553245A0 (en) PROCEDURE FOR THE PREPARATION OF HERBICIDES WITH PHOSPHONATE GROUPS.
ES2130246T3 (en) THERAPEUTIC NUCLEOSIDES SERIES 2 ', 3'-DIDESOXI-3'-FLUORO-PURINA.
MX9304133A (en) NEW DERIVATIVES OF PHOSPHOLIPIDS.
NO982755D0 (en) Covalent lipid phosphonocarboxylic acid derivatives and their use as antiviral drugs
ES2039284T3 (en) A PROCEDURE TO PREPARE DERIVATIVES OF 1-BENZOIL-2-OXO-5-ALCOXI-PIRROLIDINA.
ES2004489A4 (en) PIRIDINE GAMETOCIDES.
DK338389A (en) 6-MERCAPTOPYRIN DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE TO COMBAT RETROVIRUS INFECTIONS
FR2577422B1 (en) COMBINATION CONTAINING, AS ACTIVE INGREDIENTS, A CENTRAL ANALGESIC AND ADENINE OR ADENOSINE OR ONE OF THE ADENOSINE ANALOGS
DK86488A (en) MONOBASIC PHOSPHATE SALT OF DOBUTAMINE, PROCEDURE FOR THE PREPARATION OF SUCH SALT AND PHARMACEUTICAL PREPARATION CONTAINING SALT
BR8803997A (en) REDUCING WHEEL OF AVIATION IMPACT WITH THE SOIL
DK35288D0 (en) THIOPYRANODIPYRAZOLES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DE3579140D1 (en) MEDICINAL PRODUCTS WITH A 6-SUBSTITUTED ADENOSINE AS AN ACTIVE INGREDIENT.